Literature DB >> 16191475

Concurrent validity of WAIS-III short forms in a geriatric sample with suspected dementia: verbal, performance and full scale IQ scores.

Brian L Brooks1, Linda E Weaver.   

Abstract

Evaluation of intellectual abilities using the WAIS-III is a common component of neuropsychological assessments. However, clinicians might be interested in administering reliable and valid short forms due to practical and clinical reasons. The present study examined the concurrent validity of eight short forms of the WAIS-III with full form IQ scores in a sample (n=43) of geriatric outpatients referred for assessment of suspected dementia. There were no significant differences between the short and full form VIQ scores at P<.01, while half of the short form PIQ and FSIQ scores were significantly different from their respective full form scores at P<.01. Correlations between short and full form IQ scores ranged from .89 to .99. Seven-subtest short forms were able to accurately estimate over 80% of scores within +/-2 S.E.M.s. This study supports limited use of WAIS-III short forms when conducting evaluations of older adults with suspected dementia.

Entities:  

Mesh:

Year:  2005        PMID: 16191475     DOI: 10.1016/j.acn.2005.06.005

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  2 in total

1.  Estimation of the intelligence quotient using Wechsler Intelligence Scales in children and adolescents with Asperger syndrome.

Authors:  Jessica Merchán-Naranjo; María Mayoral; Marta Rapado-Castro; Cloe Llorente; Leticia Boada; Celso Arango; Mara Parellada
Journal:  J Autism Dev Disord       Date:  2012-01

2.  Lower [18F]fallypride binding to dopamine D2/3 receptors in frontal brain areas in adults with 22q11.2 deletion syndrome: a positron emission tomography study.

Authors:  Esther D A van Duin; Jenny Ceccarini; Jan Booij; Zuzana Kasanova; Claudia Vingerhoets; Jytte van Huijstee; Alexander Heinzel; Siamak Mohammadkhani-Shali; Oliver Winz; Felix Mottaghy; Inez Myin-Germeys; Thérèse van Amelsvoort
Journal:  Psychol Med       Date:  2019-04-02       Impact factor: 7.723

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.